Skip to main content

Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases.

Publication ,  Journal Article
Tremblay, JP; Xiao, X; Aartsma-Rus, A; Barbas, C; Blau, HM; Bogdanove, AJ; Boycott, K; Braun, S; Breakefield, XO; Bueren, JA; Buschmann, M ...
Published in: Molecular therapy : the journal of the American Society of Gene Therapy
February 2013

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Molecular therapy : the journal of the American Society of Gene Therapy

DOI

EISSN

1525-0024

ISSN

1525-0016

Publication Date

February 2013

Volume

21

Issue

2

Start / End Page

266 / 268

Related Subject Headings

  • International Cooperation
  • Humans
  • Genomics
  • Genetic Therapy
  • Biotechnology
  • Biomedical Research
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tremblay, J. P., Xiao, X., Aartsma-Rus, A., Barbas, C., Blau, H. M., Bogdanove, A. J., … Gao, G. (2013). Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Molecular Therapy : The Journal of the American Society of Gene Therapy, 21(2), 266–268. https://doi.org/10.1038/mt.2013.4
Tremblay, Jacques P., Xiao Xiao, Annemieke Aartsma-Rus, Carlos Barbas, Helen M. Blau, Adam J. Bogdanove, Kym Boycott, et al. “Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases.Molecular Therapy : The Journal of the American Society of Gene Therapy 21, no. 2 (February 2013): 266–68. https://doi.org/10.1038/mt.2013.4.
Tremblay JP, Xiao X, Aartsma-Rus A, Barbas C, Blau HM, Bogdanove AJ, et al. Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Molecular therapy : the journal of the American Society of Gene Therapy. 2013 Feb;21(2):266–8.
Tremblay, Jacques P., et al. “Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases.Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 21, no. 2, Feb. 2013, pp. 266–68. Epmc, doi:10.1038/mt.2013.4.
Tremblay JP, Xiao X, Aartsma-Rus A, Barbas C, Blau HM, Bogdanove AJ, Boycott K, Braun S, Breakefield XO, Bueren JA, Buschmann M, Byrne BJ, Calos M, Cathomen T, Chamberlain J, Chuah M, Cornetta K, Davies KE, Dickson JG, Duchateau P, Flotte TR, Gaudet D, Gersbach CA, Gilbert R, Glorioso J, Herzog RW, High KA, Huang W, Huard J, Joung JK, Liu D, Lochmüller H, Lustig L, Martens J, Massie B, Mavilio F, Mendell JR, Nathwani A, Ponder K, Porteus M, Puymirat J, Samulski J, Takeda S, Thrasher A, VandenDriessche T, Wei Y, Wilson JM, Wilton SD, Wolfe JH, Gao G. Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Molecular therapy : the journal of the American Society of Gene Therapy. 2013 Feb;21(2):266–268.

Published In

Molecular therapy : the journal of the American Society of Gene Therapy

DOI

EISSN

1525-0024

ISSN

1525-0016

Publication Date

February 2013

Volume

21

Issue

2

Start / End Page

266 / 268

Related Subject Headings

  • International Cooperation
  • Humans
  • Genomics
  • Genetic Therapy
  • Biotechnology
  • Biomedical Research
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences